Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Berry

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Thrombosis and Haemostasis|February 12, 1998
Ecarin Clotting Time: a predictive coagulation assay for the antithrombotic activity of argatroban in the ratC N Berry, C Lunven, C Girardot, et al.
Thrombosis and Haemostasis|August 26, 2000
Anticoagulant activity and pharmacokinetic properties of a sub-cutaneously administered mixed micellar formulation of argatroban in experimental animalsC N Berry, C Lunven, C Lecoffre, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitorJ Lorrain, L Millet, I Lechaire, et al.
Thrombosis and Haemostasis|April 20, 2001
Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonistC N Berry, J Lorrain, S Lochot, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Thrombosis and Haemostasis|February 12, 1998
Ecarin Clotting Time: a predictive coagulation assay for the antithrombotic activity of argatroban in the ratC N Berry, C Lunven, C Girardot, et al.
Thrombosis and Haemostasis|August 26, 2000
Anticoagulant activity and pharmacokinetic properties of a sub-cutaneously administered mixed micellar formulation of argatroban in experimental animalsC N Berry, C Lunven, C Lecoffre, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitorJ Lorrain, L Millet, I Lechaire, et al.
Thrombosis and Haemostasis|April 20, 2001
Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonistC N Berry, J Lorrain, S Lochot, et al.
Pageof 3